Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Als”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00015444
What this trial is testing

Screening and Natural History: Primary Lateral Sclerosis and Related Disorders

Who this might be right for
Primary Lateral Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 189
Not applicableStudy completedNCT02916966
What this trial is testing

Environmental Exposure and Neurological Diseases Questionnaire

Who this might be right for
Amyotrophic Lateral Sclerosis
Dartmouth-Hitchcock Medical Center 460
Testing effectiveness (Phase 2)Looking for participantsNCT06249867
What this trial is testing

Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Oliver Blanchard 30
Large-scale testing (Phase 3)Study completedNCT01776970
What this trial is testing

Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron Disease

Who this might be right for
Motor Neuron DiseaseAmyotrophic Lateral Sclerosis (ALS)
Ospedale San Raffaele 60
Testing effectiveness (Phase 2)Temporarily pausedNCT03755167
What this trial is testing

A Follow up Study to Protocol 101/2 - Continued Treatment by IPL344 IV

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Immunity Pharma Ltd. 15
Early research (Phase 1)WithdrawnNCT02588807
What this trial is testing

Food Supplement for the Treatment of Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Herb Spirit
Not applicableUnknownNCT03806634
What this trial is testing

Development and Needs Assessment and Efficiency of Smart Communication System for Patients With ALS (Part 2)

Who this might be right for
Amyotrophic Lateral Sclerosis
Taipei Veterans General Hospital, Taiwan 20
Not applicableStudy completedNCT03382392
What this trial is testing

Hypermetabolism in ALS Using Six REE Formulas

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Limoges 449
Testing effectiveness (Phase 2)Study completedNCT00696332
What this trial is testing

Talampanel for Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALS
Teva Branded Pharmaceutical Products R&D, Inc. 559
Not applicableStudy completedNCT03694132
What this trial is testing

Brain Excitability and Connectivity in Sensory-motor Pathways in ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
Institut National de la Santé Et de la Recherche Médicale, France 52
Testing effectiveness (Phase 2)Study completedNCT00800501
What this trial is testing

A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Newron Sweden AB 18
Testing effectiveness (Phase 2)WithdrawnNCT02116634
What this trial is testing

Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
Alzahra Hospital, Iran
Not applicableActive Not RecruitingNCT02327845
What this trial is testing

Phenotype, Genotype & Biomarkers in ALS and Related Disorders

Who this might be right for
Amyotrophic Lateral SclerosisFrontotemporal DementiaPrimary Lateral Sclerosis+3 more
University of Miami 708
Not applicableStudy completedNCT01984957
What this trial is testing

Differential Study of Muscle Transcriptome

Who this might be right for
ALSSMASBMA
Assistance Publique - Hôpitaux de Paris 42
Not applicableEnrolling By InvitationNCT06875739
What this trial is testing

An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman Spectroscopy

Who this might be right for
Neurodegenerative DisordersParkinson DiseaseAlzheimer Disease+3 more
Fondazione Don Carlo Gnocchi ETS 310
Early research (Phase 1)Study completedNCT04172792
What this trial is testing

Safety and Tolerability Ultra-high-caloric Food Supplements in Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Albert Christian Ludolph, Prof. 64
Not applicableNot Yet RecruitingNCT06351735
What this trial is testing

Efficacy and Safety of Deep Cervical Lymph Node-vein Bypass Surgery in ALS Amyotrophic Lateral Sclerosis

Who this might be right for
Efficacy and Safety
Second Affiliated Hospital, Zhejiang University, School of Medicine 3
Testing effectiveness (Phase 2)Study completedNCT01378676
What this trial is testing

Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Cytokinetics 49
Not applicableWithdrawnNCT04468191
What this trial is testing

Fatigue in Patients With Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral SclerosisDysphagiaDyspnea+1 more
Cara Donohue
Testing effectiveness (Phase 2)Study completedNCT00298597
What this trial is testing

Influence of G-CSF and EPO on Associative Learning and Motor Skills

Who this might be right for
Chronic StrokeAmyotrophic Lateral Sclerosis
University Hospital Muenster 180
Next Page